UM

Browse/Search Results:  1-9 of 9 Help

Selected(0)Clear Items/Page:    Sort:
Reactive versus Constitutive: Reconcile the Controversial Results about the Prognostic Value of PD-L1 Expression in cancerA Journal article
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2019,Volume: 15,Issue: 9,Page: 1933-1941
Authors:  Dapeng Hao;  Guangyu Wang;  Weiwei Yang;  Jinan Gong;  Xingmin Li;  Mingming Xiao;  Lijie He;  Li Wang;  Xiaobo Li;  Lijun Di
Favorite  |  View/Download:6/0  |  Submit date:2020/05/26
Pd-l1  Ctl  Cancer  Immunotherapy  Microenvironment  
Cytotoxic T lymphocyte trafficking and survival in an augmented fibrin matrix carrier Journal article
PLOS ONE, 2012,Volume: 7,Issue: 4
Authors:  Zhaoxia Zou;  Erin Denny;  Christine E. Brown;  Michael C. Jensen;  Gang Li;  Tatsuhiro Fujii;  Josh Neman;  Rahul Jandial;  Mike Chen
Favorite  |  View/Download:4/0  |  Submit date:2019/01/22
The immunologic aspects in advanced ovarian cancer patients treated with paclitaxel and carboplatin chemotherapy Journal article
Cancer Immunology, Immunotherapy, 2010,Volume: 59,Issue: 2,Page: 279-291
Authors:  Wu X.;  Feng Q.-M.;  Wang Y.;  Shi J.;  Ge H.-L.;  Di W.
Favorite  |  View/Download:3/0  |  Submit date:2019/01/16
Apoptosis  Chemotherapy  Immune reconstitution  Immunogenicity  Ovarian cancer  
Immunogenicities of apoptotic ovarian cancer cells induced by paclitaxel combined with cisplatin Journal article
Chinese Journal of Cancer Biotherapy, 2009,Volume: 16,Issue: 2,Page: 130-135
Authors:  Feng Q.-M.;  Wang Y.;  Ge H.-L.;  Wu X.;  Di W.
Favorite  |  View/Download:10/0  |  Submit date:2019/01/16
Apoptosis  Cisplatin  CTL  Dendritic cell  Immune response  Ovarian neoplasms  Paclitaxel  
Humoral immune responses against tumor-associated antigen OVA66 originally defined by serological analysis of recombinant cDNA expression libraries and its potentiality in cellular immunity Journal article
Cancer Science, 2008,Volume: 99,Issue: 8,Page: 1670-1678
Authors:  Jin S.;  Wang Y.;  Zhang Y.;  Zhang H.-Z.;  Wang S.-J.;  Tang J.-Q.;  Chen H.-J.;  Ge H.-L.
Favorite  |  View/Download:4/0  |  Submit date:2019/01/16
Th2-dominated antitumor immunity induced by DNA immunization with the genes coding for a basal core peptide PDTRP and GM-CSF Journal article
Cancer Gene Therapy, 2006,Volume: 13,Issue: 5,Page: 510-519
Authors:  Chu Y.;  Xia M.;  Lin Y.;  Li A.;  Wang Y.;  Liu R.;  Xiong S.
Favorite  |  View/Download:6/0  |  Submit date:2019/01/16
γ1neo-PDTRP/GM-CSF  Gene immunization  Mucin1  Th2 type  
Identification of melanoma-specific peptide epitopes by HLA-A2.1-restricted cytotoxic T lymphocytes Journal article
Acta Biochimica et Biophysica Sinica, 2006,Volume: 38,Issue: 2,Page: 110-118
Authors:  Ge H.-L.;  Wang Y.;  Wang S.-J.;  Zhang Y.
Favorite  |  View/Download:4/0  |  Submit date:2019/01/16
Cytotoxic T lymphocyte  HLA-A2.1-associated peptide  Melanoma cell line  Tumor antigenic peptide  
Single B or T-cell epitope-based DNA vaccine using modified vector induces specific immune response against hepadnavirus Journal article
Immunology Letters, 2005,Volume: 99,Issue: 2,Page: 186-192
Authors:  Xu H.-B.;  Xu W.;  Chu Y.-W.;  Wang Y.;  Xiong S.
Favorite  |  View/Download:2/0  |  Submit date:2019/01/16
B-cell epitope  DNA vaccine  Hepadnavirus  T-cell epitope  
Identification of a novel HLA-A2-restrictive CTL epitope of an ovary cancer-associated antigen OVA66 Journal article
Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology, 2005,Volume: 21,Issue: 2
Authors:  Jin S.;  Wang Y.;  Wang S.J.;  Zhang H.Z.;  Li M.X.;  Chen Y.;  Ge H.L.
Favorite  |  View/Download:3/0  |  Submit date:2019/01/16